Actualización normativa

Las vacunas líquidas eliminan la reconstitución, reducen errores y simplifican la preparación, ofreciendo mayor seguridad y practicidad.​

10 años después de su primera licencia, ​los datos clínicos, de vigilancia y comercialización confirman su favorable perfil de seguridad.

This is a practical guide to establishing islet autoantibody screening programs 

Campaña sobre concientización sobre tos ferina

Esta infografía resume la revisión sobre Hexacima®, vacuna DTaP-IPV-HB-Hib, diez años después de su autorización inicial. Experto Rev Vacunas 2023.​

Toujeo is a 2nd generation, long-acting insulin analog containing insulin glargine 300 units/mL. Toujeo® lowers blood glucose levels evenly over a long period of time. It therefore only needs to be administered once a day.

DELIVER-G: Real-world analysis in insulin-naïve adults with T2DM on GLP-1 RA ± OAD(s), intensifying their therapy by starting basal insulin and discontinuing GLP-1 RA, or adding basal insulin to ongoing GLP-1 RA, or initiating a FRC product and discontinuing current GLP-1 RA†1

First ever direct Head-to-Head Comparison of Dupilumab vs Omalizumab in Patients with Severe CRSwNP and Coexisting Asthma.

First ever direct Head-to-Head Comparison of Dupilumab vs Omalizumab in Patients with Severe CRSwNP and Coexisting Asthma.

First ever direct Head-to-Head Comparison of Dupilumab vs Omalizumab in Patients with Severe CRSwNP and Coexisting Asthma.

First ever direct Head-to-Head Comparison of Dupilumab vs Omalizumab in Patients with Severe CRSwNP and Coexisting Asthma.